Drug Profile
Research programme: hepatitis C therapy - Immtech
Alternative Names: HCV therapies - ImmtechLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Immtech Pharmaceuticals
- Class
- Mechanism of Action DNA inhibitors; Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis C